Furthermore, in a recent study with 1,423 lung cancer patients, Yan et al. found significantly increased levels in blood CD3+ T-cells, especially CD8+ T cells, compared to CD4+ T cells in the patients 3 months after RT of the lung (174). The gene discussed is CD4; the disease is lung cancer.